Self-Guided Fund Manager I Family Offices & Institutional Investors I ASEAN I Tomahawk Capital for US Individuals

Overview

We offer a strategic opportunity for biotech businesses to significantly increase the value of their business through our roll-up strategy. By consolidating multiple businesses and leveraging the higher PE ratios of publicly traded companies, owners can achieve a much higher exit valuation than selling independently.

Key Points of the Value Proposition

Substantially Higher Exit Valuation:

Private Market Sale Value: Typically, businesses are valued at around 5x EBITDA when sold privately.

Public Market Exit Value: Through our roll-up strategy, your business(es) can be part of a larger entity valued at 40x EBITDA in the public market.

Calculation of Potential Gains:

Current Value of Your Business:

If sold privately: $1 million EBITDA * 5 = $5 million.

Value Through Our Roll-Up Strategy:

Public market valuation: $1 million EBITDA * 40 = $40 million.

Upside Created:

Public market valuation - private market valuation = $40 million - $5 million = $35 million.

Shared Upside:

Your Share of the Upside:

We offer you 50% of the $35 million upside.

Your share = 50% * $35 million = $17.5 million.

Total Value to You:

Initial private sale value + your share of the upside = $5 million + $17.5 million = $22.5 million.

Comparison:

Private Sale:

Valuation = $5 million.

Through Our Roll-Up:

Total valuation = $22.5 million.

This represents a 4.5x higher return ($22.5 million / $5 million).

Illustrative Breakdown:

Private Sale:

You receive $5 million.

With Our Roll-Up:

Initial private valuation: $5 million.

Plus 50% of the upside ($17.5 million).

Total: $22.5 million.

Outcome:

Gain an extra $17.5 million.

Equivalent to a 4.5x higher return.

Additional Benefits:

Reduced Risk: Gains are aligned with actual market performance, reducing your financial risk.

Professional Management: Benefit from experienced management and operational efficiencies.

Strategic Growth: Enhanced growth prospects through combined resources and synergies.

Simple Terms

Sell Privately: Receive $5 million.

Join Our Roll-Up: Receive $22.5 million.

Extra Gain: $17.5 million.

Return: 4.5x higher.

Conclusion

By partnering with us, you can maximize your business's value through our roll-up strategy. This ensures a strong initial valuation and significant participation in the upside of the public market, resulting in a much higher exit valuation. Would you prefer to sell your practice for $5 million or for $22.5 million? Join us and transform your biotech business’s valuation today.